Biological activities of leupeptins.
D000596:Amino Acids / Q000494:pharmacology*; D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D002364:Caseins / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D002918:Chymotrypsin / Q000037:antagonists & inhibitors; D004285:Dogs; D004789:Enzyme Activation; D005340:Fibrinogen / Q000037:antagonists & inhibitors; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D006801:Humans; D007610:Kallikreins / Q000037:antagonists & inhibitors; D010206:Papain / Q000037:antagonists & inhibitors; D010447:Peptide Hydrolases / Q000032:analysis; D010958:Plasminogen / Q000037:antagonists & inhibitors; D011480:Protease Inhibitors; D011817:Rabbits; D051381:Rats; D013300:Streptokinase / Q000037:antagonists & inhibitors; D013917:Thrombin / Q000037:antagonists & inhibitors; D013925:Thromboplastin / Q000037:antagonists & inhibitors; D014361:Trypsin Inhibitors
D000596:Amino Acids; D000614:Aminocaproates; D002364:Caseins; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D005340:Fibrinogen; D010958:Plasminogen; D013925:Thromboplastin; D010447:Peptide Hydrolases; D013300:Streptokinase; D007610:Kallikreins; D002918:Chymotrypsin; D013917:Thrombin; D005341:Fibrinolysin; D010206:Papain